GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Episurf Medical AB (OSTO:EPIS B) » Definitions » 1-Year Sharpe Ratio

Episurf Medical AB (OSTO:EPIS B) 1-Year Sharpe Ratio : -1.99 (As of Jul. 07, 2025)


View and export this data going back to 2010. Start your Free Trial

What is Episurf Medical AB 1-Year Sharpe Ratio?

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2025-07-07), Episurf Medical AB's 1-Year Sharpe Ratio is -1.99.


Competitive Comparison of Episurf Medical AB's 1-Year Sharpe Ratio

For the Medical Devices subindustry, Episurf Medical AB's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Episurf Medical AB's 1-Year Sharpe Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Episurf Medical AB's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Episurf Medical AB's 1-Year Sharpe Ratio falls into.


;
;

Episurf Medical AB 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.


Episurf Medical AB  (OSTO:EPIS B) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.


Episurf Medical AB 1-Year Sharpe Ratio Related Terms

Thank you for viewing the detailed overview of Episurf Medical AB's 1-Year Sharpe Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Episurf Medical AB Business Description

Traded in Other Exchanges
Address
Karlavagen 60, Stockholm, SWE, 114 49
Episurf Medical AB is a medical device company. The company develops, manufactures, and commercializes solutions for the repair of the local cartilage damage in human joints. Its first patient-specific product portfolio, the knee portfolio, consists of the existing products Episealer Condyle Solo and Episealer Trochlea Solo, Episealer Femoral Twin, Epiguide MOS, and Epioscopy. Episealer Patellofemoral System for the treatment of osteoarthritis limited to thepatellofemoral part of the knee joint.

Episurf Medical AB Headlines

No Headlines